Observational studies have determined hyperphosphatemia to be a cardiovascular risk
factor in chronic kidney disease. Mechanistic studies have elucidated that …

Hyperphosphataemia is a frequent and important cardiovascular risk factor in patients with
chronic kidney disease (CKD). High phosphate levels may influence vascular calcifications …

Hyperphosphatemia has consistently been shown to be associated with dismal outcome in a
wide variety of populations, particularly in chronic kidney disease (CKD). Compelling …

Vascular calcification is associated with significant cardiovascular morbidity and mortality in
patients with chronic kidney disease (CKD). Factors unique to patients with CKD, such as …

New advances in the pathogenesis of renal osteodystrophy (ROD) change the perspective
from which many of its features and treatment are viewed. Calcium, phosphate, parathyroid …

Abstract Background and Aim: Due to increasing evidence suggesting a link between
hyperphosphatemia and cardiovascular disease (CVD), mediated through vascular …

Chronic kidney disease (CKD) is characterized by high cardiovascular morbidity/mortality,
which is linked in part to vascular calcification (VC) and endothelial dysfunction (ED) …

Hyperphosphatemia is a common complication in patients with chronic kidney disease
(CKD), particularly in those requiring renal replacement therapy. The importance of …

Vascular calcification is recognized as a major contributor to cardiovascular disease (CVD)
in end stage renal disease (ESRD) patients. Susceptibility to vascular calcification is …

VASCULAR calcification, specifically arte-rial calcification, has been recognized for many
years as a common complication of chronic kidney disease (CKD). 1-3 The mechanisms …